Skip to content

Research and development, transformation and application of hierarchical diagnosis and treatment technology for somatic diseases complicated with depression and anxiety disorders

Research and development, transformation and application of hierarchical diagnosis and treatment technology for somatic diseases complicated with depression and anxiety disorders

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400089174
Enrollment
Unknown
Registered
2024-09-03
Start date
2016-08-01
Completion date
Unknown
Last updated
2024-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Physical diseases were associated with anxiety and depression

Interventions

Post-stroke depression group:Escitalopram
Depression and anxiety caused by coronary heart disease:Sertraline
Depression and anxiety caused by diabetes:Bupropion

Sponsors

The Second Xiangya Hospital, Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 89 Years

Inclusion criteria

Inclusion criteria: The patient is able to cooperate with all research procedures, has signed an informed consent form, and voluntarily participates in this clinical study. The inclusion criteria are as follows: aged 18-89 years; meeting the diagnostic criteria for neurological diseases such as stroke, cardiovascular diseases like coronary heart disease, and endocrine diseases such as type 2 diabetes, with stable physical conditions, and accompanied by depressive and anxiety disorders. In the past 3 months, the patient has not received electroconvulsive therapy or repetitive transcranial magnetic stimulation (rTMS) treatment.

Exclusion criteria

Exclusion criteria: Exclusion criteria included significant comorbid physical illnesses or organic brain disorders, a history of alcohol or substance dependence or abuse, comorbid psychiatric disorders, current severe suicidal ideation or behavior, pregnancy, or lactating women.

Design outcomes

Primary

MeasureTime frame
Hierarchical Diagnostic and Treatment Technology;

Countries

China

Contacts

Public ContactGuo Wenbin

The Second Xiangya Hospital, Central South University

guowenbin76@czu.edu.cn+86 130 5690 9656

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026